Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy

医学 心脏再同步化治疗 临床终点 心脏病学 内科学 心力衰竭 置信区间 铅(地质) 随机对照试验 随机化
作者
Fakhar Z. Khan,Mumohan S. Virdee,Christopher R. Palmer,Peter J. Pugh,Denis O’Halloran,Maros Elsik,Philip A. Read,David Begley,Simon P. Fynn,David P. Dutka
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:59 (17): 1509-1518 被引量:506
标识
DOI:10.1016/j.jacc.2011.12.030
摘要

This study sought to assess the impact of targeted left ventricular (LV) lead placement on outcomes of cardiac resynchronization therapy (CRT). Placement of the LV lead to the latest sites of contraction and away from the scar confers the best response to CRT. We conducted a randomized, controlled trial to compare a targeted approach to LV lead placement with usual care. A total of 220 patients scheduled for CRT underwent baseline echocardiographic speckle-tracking 2-dimensional radial strain imaging and were then randomized 1:1 into 2 groups. In group 1 (TARGET [Targeted Left Ventricular Lead Placement toGuide Cardiac Resynchronization Therapy]), the LV lead was positioned at the latest site of peak contraction with an amplitude of >10% to signify freedom from scar. In group 2 (control) patients underwent standard unguided CRT. Patients were classified by the relationship of the LV lead to the optimal site as concordant (at optimal site), adjacent (within 1 segment), or remote (≥2 segments away). The primary endpoint was a ≥15% reduction in LV end-systolic volume at 6 months. Secondary endpoints were clinical response (≥1 improvement in New York Heart Association functional class), all-cause mortality, and combined all-cause mortality and heart failure–related hospitalization. The groups were balanced at randomization. In the TARGET group, there was a greater proportion of responders at 6 months (70% vs. 55%, p = 0.031), giving an absolute difference in the primary endpoint of 15% (95% confidence interval: 2% to 28%). Compared with controls, TARGET patients had a higher clinical response (83% vs. 65%, p = 0.003) and lower rates of the combined endpoint (log-rank test, p = 0.031). Compared with standard CRT treatment, the use of speckle-tracking echocardiography to the target LV lead placement yields significantly improved response and clinical status and lower rates of combined death and heart failure–related hospitalization. (Targeted Left Ventricular Lead Placement to Guide Cardiac Resynchronization Therapy [TARGET] study); ISRCTN19717943 )
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
bkagyin应助科研通管家采纳,获得10
3秒前
隐形曼青应助科研通管家采纳,获得10
3秒前
彭于晏应助科研通管家采纳,获得10
3秒前
FashionBoy应助科研通管家采纳,获得10
3秒前
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
汉堡包应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
hnu301完成签到,获得积分10
4秒前
英姑应助冷酷鱼采纳,获得10
5秒前
5秒前
屿落完成签到,获得积分10
5秒前
昏睡的蟠桃应助zzz采纳,获得100
5秒前
量子星尘发布了新的文献求助10
7秒前
恋雅颖月应助幸福大白采纳,获得10
7秒前
wh完成签到,获得积分10
7秒前
余淮完成签到,获得积分10
8秒前
平淡的初翠完成签到,获得积分10
8秒前
快乐一江发布了新的文献求助10
9秒前
邱型程应助屿落采纳,获得20
10秒前
鹤鸣完成签到,获得积分10
13秒前
13秒前
13秒前
15秒前
天真的高山完成签到,获得积分10
16秒前
善良海云完成签到,获得积分10
18秒前
ANG发布了新的文献求助10
18秒前
从容梦旋完成签到,获得积分10
20秒前
21秒前
酷波er应助liuyunhao7207采纳,获得10
21秒前
人生如梦应助健忘跳跳糖采纳,获得10
22秒前
22秒前
sihanzhiyu发布了新的文献求助10
22秒前
汉堡包应助dpp采纳,获得10
22秒前
在水一方应助hnu301采纳,获得10
22秒前
jbhb完成签到,获得积分20
23秒前
Colossus完成签到,获得积分10
23秒前
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989406
求助须知:如何正确求助?哪些是违规求助? 3531522
关于积分的说明 11254187
捐赠科研通 3270174
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174